Our Recent Posts

OrthAlign, Inc. Announces First Cases Using Lantern® Hip; The Next Evolution in Total Hip Replacement Technology

OrthAlign Receives FDA 510(k) Clearance for Lantern® Hip

Catalyst OrthoScience Surpasses 10,000 Total Shoulder Arthroplasty (TSA) Procedures and Announces $20 Million Financing

Merry Christmas & Happy New Year!

We are blessed here at MCP as we have wonderful investors, a healthy portfolio, and continued successful exits. Best wishes for a strong finish to 2016 and a great 2017!

OrthAlign, Inc. Announces First Cases Using Lantern® Hip; The Next Evolution in Total Hip Replacement Technology

OrthAlign Receives FDA 510(k) Clearance for Lantern® Hip

Catalyst OrthoScience Surpasses 10,000 Total Shoulder Arthroplasty (TSA) Procedures and Announces $20 Million Financing

Merry Christmas & Happy New Year!

©2024 by Mutual Capital Partners